Evidence mapPaperPMID 30914970Full record

ArticleFrontiers in physiology2019

Effectiveness of a Novel Nutraceutical Compound Containing Red Yeast Rice, Polymethoxyflavones and Antioxidants in the Modulation of Cholesterol Levels in Subjects With Hypercholesterolemia and Low-Moderate Cardiovascular Risk: The NIRVANA Study.

Paolo Cimaglia, Francesco Vieceli Dalla Sega, Francesco Vitali, Veronica Lodolini, Davide Bernucci, Giulia Passarini, Francesca Fortini, Luisa Marracino, Giorgio Aquila, Paola Rizzo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Ticagrelor IncreasesInternational journal of molecular sciences · 2020
    Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Nanonutraceuticals: The New Frontier of Supplementary Food.Nanomaterials (Basel, Switzerland) · 2021
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Paolo CimagliaCardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
Francesco Vieceli Dalla SegaMaria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
Francesco VitaliCardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
Veronica LodoliniCardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
Davide BernucciCardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
Giulia PassariniCardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
Francesca FortiniMaria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
Luisa MarracinoDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Giorgio AquilaDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Paola RizzoMaria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
Roberto FerrariCardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
Gianluca CampoCardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
Arcispedale Sant'Anna · ITMaria Cecilia Hospital · ITUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiovascular preventionendothelial functionhypercholesterolemianutraceutical compoundred yeast rice

Identifiers

PMID30914970
PMCPMC6421317
OpenAlexW2920922550

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.